Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ennio Polilli

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Liver International : Official Journal of the International Association for the Study of the Liver|January 26, 2021
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-CVelia Chiara Di Maio, Silvia Barbaliscia, Elisabetta Teti, et al.
Scientific Reports|June 14, 2018
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in ItalyAda Bertoli, Maria Chiara Sorbo, Marianna Aragri, et al.
Viruses|April 30, 2021
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1bMohammad Alkhatib, Velia Chiara Di Maio, Valentina De Murtas, et al.
Plos One|May 26, 2017
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimensValeria Cento, Thi Huyen Tram Nguyen, Domenico Di Carlo, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Liver International : Official Journal of the International Association for the Study of the Liver|January 26, 2021
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-CVelia Chiara Di Maio, Silvia Barbaliscia, Elisabetta Teti, et al.
Scientific Reports|June 14, 2018
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in ItalyAda Bertoli, Maria Chiara Sorbo, Marianna Aragri, et al.
Viruses|April 30, 2021
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1bMohammad Alkhatib, Velia Chiara Di Maio, Valentina De Murtas, et al.
Plos One|May 26, 2017
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimensValeria Cento, Thi Huyen Tram Nguyen, Domenico Di Carlo, et al.
Pageof 7